Circulating Tumor DNA Testing Supports Rapid Therapeutic Decision-Making in Metastatic Melanoma: A Case Report

Treatment of metastatic melanoma includes the option of targeted therapy in patients with driver BRAF mutations. BRAF-MEK inhibitor drugs improve survival in the approximately 50% of patients with melanoma that harbor BRAF mutations. As BRAF mutation detection in tissue often takes days to weeks, it...

Descripción completa

Detalles Bibliográficos
Autores principales: Behera, Tapas Ranjan, Song, Jung Min, Ko, Jennifer, Eicher, Donald, Arbesman, Joshua, Gastman, Brian, Farkas, Daniel H., Funchain, Pauline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231430/
https://www.ncbi.nlm.nih.gov/pubmed/35756682
http://dx.doi.org/10.3389/fonc.2022.846187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231430/
https://www.ncbi.nlm.nih.gov/pubmed/35756682
http://dx.doi.org/10.3389/fonc.2022.846187

Ejemplares similares